Diagnostic Considerations for Gastrointestinal Symptoms in POTS Patients

Primary Diagnostic Considerations

Nausea, abdominal pain, vomiting, diarrhea, bloating, and severe constipation are common in POTS, with nausea, pain, and early satiety being the most predictive of abnormal GI motility, according to the American Gastroenterological Association 1
DGBI evaluation should follow a positive symptom-based diagnostic strategy with limited noninvasive testing, similar to the general population, as recommended by the American Gastroenterological Association 2
Visceral hypersensitivity and/or dysmotility are common mechanisms underlying these symptoms in POTS patients, with a strength of evidence level of moderate, according to the American Gastroenterological Association 1
Timely diagnostic testing of gastric motor functions (gastric emptying and/or accommodation) should be considered earlier in POTS patients with chronic upper GI symptoms, as abnormal gastric emptying may be more common than in the general population, according to the American Gastroenterological Association 2
The underlying autonomic dysfunction in POTS predisposes to gastroparesis and perturbations in GI motility, with a high level of evidence, according to the American Gastroenterological Association 3

Test for celiac disease earlier in the diagnostic workup, as the risk is elevated in patients with POTS and hEDS, even without isolated diarrhea, according to the American Gastroenterological Association 2, 4
Assess for opioid use, as opioids can cause or exacerbate GI dysmotility and should be avoided or withdrawn, with a high level of evidence, according to the American Gastroenterological Association 2, 5
If constipation or incomplete evacuation is present, perform anorectal manometry, balloon expulsion test, or defecography to evaluate for pelvic floor dysfunction, which has high prevalence in this population, especially rectal hyposensitivity, according to the American Gastroenterological Association 2

For abdominal pain: Consider acid-suppressive drugs (PPIs, H2 antagonists), antispasmodics (hyoscyamine, dicyclomine, peppermint oil), and neuromodulators (TCAs, SSRIs, SNRIs, pregabalin, gabapentin) based on pain location, type, and frequency, with a moderate level of evidence, according to the American Gastroenterological Association 2
Avoid opiates specifically for abdominal pain treatment, with a high level of evidence, according to the American Gastroenterological Association 2
For nausea/vomiting: Use antiemetics (ondansetron, promethazine, prochlorperazine, aprepitant) and prokinetics (metoclopramide, domperidone, erythromycin, prucalopride), with a moderate level of evidence, according to the American Gastroenterological Association 2

Do not attribute all symptoms to POTS alone—systematically evaluate for overlapping conditions like hEDS, MCAS, and DGBI, with a high level of evidence, according to the American Gastroenterological Association 2, 1
Do not delay gastric emptying studies in POTS patients with upper GI symptoms, as the threshold for testing should be lower than in the general population, with a high level of evidence, according to the American Gastroenterological Association 2, 3
Do not prescribe opioids for pain management, as they worsen GI dysmotility and should be withdrawn if already prescribed, with a high level of evidence, according to the American Gastroenterological Association 2, 5
Do not overlook pelvic floor dysfunction in patients with constipation or incomplete evacuation, with a moderate level of evidence, according to the American Gastroenterological Association 2

Vagus nerve dysfunction is recognized as a key mechanism causing gastroparesis in POTS, and treatment should follow a stepwise approach that begins with dietary modification, proceeds to prokinetics for delayed emptying, and uses neuromodulators for pain while strictly avoiding opioids. 6
Vagal nerve injury is specifically identified as one of the putative factors generating refractory gastroparesis symptoms in POTS patients. 6
POTS is a form of dysautonomia that can involve peripheral nerves, autonomic ganglia, spinal cord, and brain, leading to alimentary‑tract defects; the vagus nerve, as part of the parasympathetic system, directly innervates the gastrointestinal tract and controls gastric motility. [7][8]

Gastric emptying scintigraphy using a radiolabeled solid meal performed for up to 4 hours is the best‑accepted method to diagnose delayed gastric emptying. 9

Initiate a diet of small particle size, reduced fat, and low fiber as the foundation of gastroparesis management in POTS. 10

Identify the predominant symptom and treat accordingly:
- Nausea/Vomiting – employ antiemetics (e.g., ondansetron, promethazine) and, when delayed emptying is documented, first‑line prokinetic metoclopramide (alternatives include domperidone, erythromycin, prucalopride). 6
- Abdominal Pain – use neuromodulators such as tricyclic antidepressants, SSRIs, SNRIs, pregabalin, or gabapentin; opioids must be avoided. 6

Gastric electrical stimulation (GES) may be considered for patients with refractory nausea/vomiting who have failed standard therapy and are not on opioids. 6
Gastric per‑oral endoscopic myotomy (G‑POEM) can be contemplated for select patients with severe delayed gastric emptying refractory to conventional treatment, within a multidisciplinary team at a center of excellence. 6

Individuals with hypermobile Ehlers‑Danlos syndrome or hypermobile spectrum disorders have a 37.5 % prevalence of POTS; when POTS co‑exists, there is a higher likelihood of irritable bowel syndrome, gastro‑esophageal reflux disease, or other dysmotility disorders. 7